1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION AND SCOPE 29
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.2.2 MARKET SEGMENTATION 30
FIGURE 1 ATP ASSAYS MARKET SEGMENTATION 30
FIGURE 2 ATP ASSAYS MARKET: REGIONAL SEGMENTATION 31
1.2.3 YEARS CONSIDERED 31
1.3 CURRENCY CONSIDERED 32
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 3 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 36
FIGURE 4 PRIMARY SOURCES 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Key industry insights 37
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 38
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 39
2.2 MARKET SIZE ESTIMATION 39
FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 40
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC INC. 40
FIGURE 10 GLOBAL ATP ASSAYS MARKET: BY PRODUCT 41
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
FIGURE 12 CAGR PROJECTIONS: ATP ASSAYS MARKET 42
FIGURE 13 TOP-DOWN APPROACH 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 14 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET RANKING ANALYSIS 45
2.5 STUDY ASSUMPTIONS 45
2.6 RESEARCH LIMITATIONS 45
2.6.1 METHODOLOGY-RELATED LIMITATIONS 45
2.6.2 SCOPE-RELATED LIMITATIONS 46
2.7 RISK ASSESSMENT 46
TABLE 2 RISK ASSESSMENT: ATP ASSAYS MARKET 46
2.8 RECESSION IMPACT ON ATP ASSAYS MARKET 46
TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 47
TABLE 4 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 47
TABLE 5 US HEALTHCARE EXPENDITURE, 2023–2027 (USD MILLION) 47
3 EXECUTIVE SUMMARY 48
FIGURE 15 ATP ASSAYS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 48
FIGURE 16 ATP ASSAYS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 49
FIGURE 17 ATP ASSAYS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 49
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF ATP ASSAYS MARKET 50
4 PREMIUM INSIGHTS 52
4.1 ATP ASSAYS MARKET OVERVIEW 52
FIGURE 19 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET 52
4.2 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2022) 53
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ATP ASSAYS MARKET IN 2022 53
4.3 ATP ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 54
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE IN ATP ASSAYS MARKET DURING FORECAST PERIOD 54
4.4 ATP ASSAYS MARKET, BY REGION (2023–2028) 55
FIGURE 22 NORTH AMERICA TO DOMINATE GLOBAL ATP ASSAYS MARKET IN 2028 55
4.5 ATP ASSAYS MARKET: DEVELOPED VS. EMERGING ECONOMIES 55
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 24 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
TABLE 6 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing food safety concerns globally 58
5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies 59
5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D 59
FIGURE 25 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION) 60
5.2.1.4 Increasing prevalence of cancer globally 60
TABLE 7 ESTIMATED NEW CANCER CASES IN US, 2023 61
FIGURE 26 GLOBAL CANCER INCIDENCE AND MORTALITY, 2020 61
5.2.1.5 Shift from culture-based tests to rapid tests 62
5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases 62
5.2.2 RESTRAINTS 63
5.2.2.1 High cost of instruments and reagents 63
5.2.2.2 Inability to differentiate between extracellular and intracellular ATP 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Technological enhancements in ATP assay probes 64
5.2.3.2 Growth prospects in emerging economies 65
5.2.4 CHALLENGES 66
5.2.4.1 Low survival rate for small players and new entrants 66
5.3 INDUSTRY TRENDS 66
5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES 66
5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2 67
5.4 TECHNOLOGY ANALYSIS 67
5.4.1 HOMOGENEOUS TIME-RESOLVED FLUORESCENCE TECHNOLOGY FOR RAPID SCREENING OF ATP CONCENTRATIONS 67
5.4.2 EASE OF USE OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYZERS IN CLINICAL LABORATORIES 67
5.4.3 ADVANCED ASSAY STABILITY (AAS) SYSTEMS TO MATCH ROOM TEMPERATURE WHILE PERFORMING ASSAYS 68
5.4.4 OTHER TECHNOLOGICAL INNOVATIONS 68
5.5 REGULATORY ANALYSIS 69
5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.5.1.1 North America 69
5.5.1.1.1 US 69
5.5.1.1.2 Canada 69
5.5.1.2 Europe 70
5.5.1.3 Asia Pacific 70
5.5.1.4 Rest of the World 71
5.6 PATENT ANALYSIS 71
5.6.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS 71
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023) 72
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 72
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–JUNE 2023) 73
5.6.3 LIST OF PATENTS/PATENT APPLICATIONS IN ATP ASSAYS MARKET 74
5.7 VALUE CHAIN ANALYSIS 75
FIGURE 29 ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS 76
5.8 ECOSYSTEM MARKET MAP 76
FIGURE 30 ATP ASSAYS MARKET: ECOSYSTEM MARKET MAP 77
5.9 PORTER’S FIVE FORCES ANALYSIS 77
TABLE 8 ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 77
5.9.1 THREAT OF NEW ENTRANTS 77
5.9.2 THREAT OF SUBSTITUTES 78
5.9.3 BARGAINING POWER OF SUPPLIERS 78
5.9.4 BARGAINING POWER OF BUYERS 78
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.10 PRICING ANALYSIS 79
5.10.1 AVERAGE SELLING PRICE, BY KEY PLAYER 80
TABLE 9 AVERAGE SELLING PRICE, BY KEY PLAYER 80
TABLE 10 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD) 80
5.10.2 AVERAGE SELLING PRICE TREND 81
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024 81
TABLE 11 ATP ASSAYS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024 81
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 82
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 82
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ATP ASSAY PRODUCTS 82
5.12.2 BUYING CRITERIA FOR ATP ASSAYS 82
FIGURE 32 KEY BUYING CRITERIA FOR END USERS 82
6 ATP ASSAYS MARKET, BY APPLICATION 83
6.1 INTRODUCTION 84
TABLE 12 ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 84
6.2 CONTAMINATION TESTING 84
6.2.1 INCREASING REQUIREMENTS TO MEET REGULATORY MANDATES FOR QUALITY TESTING TO DRIVE MARKET 84
TABLE 13 ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.3 DISEASE TESTING 85
6.3.1 GROWING DISEASE INCIDENCE AND RISING PATIENT AWARENESS TO DRIVE MARKET 85
TABLE 14 ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.4 DRUG DISCOVERY & DEVELOPMENT 87
6.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS TO DRIVE MARKET 87
TABLE 15 ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 88
7 ATP ASSAYS MARKET, BY PRODUCT 89
7.1 INTRODUCTION 90
TABLE 16 ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 90
7.2 CONSUMABLES & ACCESSORIES 90
TABLE 17 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE 91
TABLE 18 ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 19 ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 92
7.2.1 REAGENTS & KITS 92
7.2.1.1 Growing prevalence of infectious diseases and increasing use of contamination testing to drive segment 92
TABLE 20 REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
7.2.2 MICROPLATES 94
7.2.2.1 Increasing demand in drug discovery and preclinical safety studies to drive segment 94
TABLE 21 MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
7.2.3 OTHER CONSUMABLES & ACCESSORIES 95
TABLE 22 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
7.3 INSTRUMENTS 96
TABLE 23 ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 24 ATP ASSAYS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 25 KEY ATP INSTRUMENTS AVAILABLE 98
7.3.1 LUMINOMETERS 98
7.3.1.1 Low cost, quick output, and ease of usage to drive segment 98
TABLE 26 LUMINOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
7.3.2 SPECTROPHOTOMETERS 99
7.3.2.1 Higher cost of spectrophotometers to limit market 99
TABLE 27 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
8 ATP ASSAYS MARKET, BY END USER 101
8.1 INTRODUCTION 102
TABLE 28 ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 102
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 102
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE ATP ASSAYS END USER MARKET DURING STUDY PERIOD 102
TABLE 29 ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 103
8.3 FOOD & BEVERAGE INDUSTRY 104
8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION AND GROWING NEED FOR FOOD SAFETY TO DRIVE MARKET 104
TABLE 30 ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 105
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES 105
8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET 105
TABLE 31 ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 106
8.5 ACADEMIC & RESEARCH INSTITUTES 107
8.5.1 INCREASING USE IN CELL CULTURE EXPERIMENTS AND CANCER RESEARCH TO DRIVE MARKET 107
TABLE 32 ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 108
9 ATP ASSAYS MARKET, BY REGION 109
9.1 INTRODUCTION 110
TABLE 33 ATP ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
9.2 NORTH AMERICA 111
9.2.1 NORTH AMERICA: RECESSION IMPACT 112
FIGURE 34 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT 113
TABLE 34 NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 35 NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 114
TABLE 36 NORTH AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 37 NORTH AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 38 NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 115
TABLE 39 NORTH AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 115
9.2.2 US 116
9.2.2.1 US to dominate North American ATP assays market during forecast period 116
TABLE 40 US: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 116
TABLE 41 US: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 42 US: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 43 US: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 117
TABLE 44 US: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 118
9.2.3 CANADA 118
9.2.3.1 Government funding programs for life science research to drive market 118
TABLE 45 CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 119
TABLE 46 CANADA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 47 CANADA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 48 CANADA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 120
TABLE 49 CANADA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 120
9.3 EUROPE 121
9.3.1 EUROPE: RECESSION IMPACT 121
TABLE 50 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 51 EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
TABLE 52 EUROPE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 53 EUROPE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 54 EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 55 EUROPE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 124
9.3.2 GERMANY 124
9.3.2.1 Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers to drive market 124
TABLE 56 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 125
TABLE 57 GERMANY: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 58 GERMANY: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 59 GERMANY: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 60 GERMANY: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 126
9.3.3 UK 127
9.3.3.1 Increasing R&D expenditure in pharmaceutical companies and growing life science industry to drive market 127
FIGURE 35 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION) 128
TABLE 61 UK: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 62 UK: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 63 UK: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 64 UK: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 129
TABLE 65 UK: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 129
9.3.4 FRANCE 130
9.3.4.1 Highly profitable agro-food sector and increased focus on biotechnology R&D to drive market 130
TABLE 66 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 67 FRANCE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 68 FRANCE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 69 FRANCE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
TABLE 70 FRANCE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 132
9.3.5 ITALY 132
9.3.5.1 Presence of well-developed healthcare system and high cancer burden to drive market 132
TABLE 71 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
TABLE 72 ITALY: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 73 ITALY: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 74 ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 75 ITALY: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 134
9.3.6 SPAIN 134
9.3.6.1 Growth in personalized medicines and clinical diagnostics to drive market 134
TABLE 76 SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 135
TABLE 77 SPAIN: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 78 SPAIN: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 79 SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 136
TABLE 80 SPAIN: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 136
9.3.7 REST OF EUROPE 137
TABLE 81 REST OF EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 137
TABLE 82 REST OF EUROPE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 83 REST OF EUROPE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 84 REST OF EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 85 REST OF EUROPE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 139
9.4 ASIA PACIFIC 139
9.4.1 ASIA PACIFIC: RECESSION IMPACT 140
FIGURE 36 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT 141
TABLE 86 ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 87 ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 88 ASIA PACIFIC: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 89 ASIA PACIFIC: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 90 ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 91 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 143
9.4.2 CHINA 144
9.4.2.1 Increasing pharmaceutical R&D investments to drive market 144
TABLE 92 CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 144
TABLE 93 CHINA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 94 CHINA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 95 CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 96 CHINA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 146
9.4.3 JAPAN 146
9.4.3.1 Higher incidence of cancer and greater geriatric population to drive market 146
TABLE 97 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 147
TABLE 98 JAPAN: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 99 JAPAN: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 100 JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 101 JAPAN: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 148
9.4.4 INDIA 148
9.4.4.1 Growing adoption of ATP assay techniques in research and clinical applications to drive market 148
TABLE 102 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 149
TABLE 103 INDIA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 104 INDIA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 105 INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 106 INDIA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 150
9.4.5 REST OF ASIA PACIFIC 151
TABLE 107 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 151
TABLE 108 REST OF ASIA PACIFIC: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 109 REST OF ASIA PACIFIC: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 110 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 111 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 153
9.5 LATIN AMERICA 153
9.5.1 LATIN AMERICA: RECESSION IMPACT 154
TABLE 112 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 113 LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 114 LATIN AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 115 LATIN AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 116 LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 117 LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 156
9.5.2 BRAZIL 156
9.5.2.1 Increasing research activities and growing pharmaceutical industry to drive market 156
TABLE 118 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 119 BRAZIL: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 120 BRAZIL: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 121 BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 122 BRAZIL: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 158
9.5.3 MEXICO 158
9.5.3.1 Increase in research centers and manufacturing units to drive market 158
TABLE 123 MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 124 MEXICO: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 125 MEXICO: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 126 MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 127 MEXICO: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 160
9.5.4 REST OF LATIN AMERICA 160
TABLE 128 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 161
TABLE 129 REST OF LATIN AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 130 REST OF LATIN AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 131 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 162
TABLE 132 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 162
9.6 MIDDLE EAST & AFRICA 163
9.6.1 GROWING FUNDING INITIATIVES AND INCREASING STRATEGIC PARTNERSHIPS TO DRIVE MARKET 163
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 163
TABLE 133 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 134 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 135 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 136 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 137 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10 COMPETITIVE LANDSCAPE 166
10.1 OVERVIEW 166
10.2 STRATEGIES ADOPTED BY MAJOR PLAYERS 166
TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ATP ASSAYS MARKET 166
10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 169
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN ATP ASSAYS MARKET 169
10.4 MARKET RANKING OF KEY PLAYERS IN ATP ASSAYS MARKET 169
FIGURE 38 ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2022 170
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 171
10.5.1 STARS 171
10.5.2 EMERGING LEADERS 171
10.5.3 PERVASIVE PLAYERS 171
10.5.4 PARTICIPANTS 171
FIGURE 39 ATP ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 172
10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 172
10.6.1 PROGRESSIVE COMPANIES 172
10.6.2 DYNAMIC COMPANIES 173
10.6.3 STARTING BLOCKS 173
10.6.4 RESPONSIVE COMPANIES 173
FIGURE 40 ATP ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 173
10.7 COMPANY FOOTPRINT 174
TABLE 139 COMPANY FOOTPRINT: ATP ASSAYS MARKET (2022) 174
10.7.1 PRODUCT FOOTPRINT 175
TABLE 140 PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2022) 175
10.7.2 APPLICATION FOOTPRINT 176
TABLE 141 APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2022) 176
10.7.3 END USER FOOTPRINT 177
TABLE 142 END USER FOOTPRINT: ATP ASSAYS MARKET (2022) 177
10.7.4 GEOGRAPHICAL FOOTPRINT 178
TABLE 143 REGIONAL FOOTPRINT: ATP ASSAYS MARKET (2022) 178
10.8 COMPETITIVE SCENARIOS AND TRENDS 179
10.8.1 KEY PRODUCT LAUNCHES 179
TABLE 144 KEY PRODUCT LAUNCHES, JANUARY 2019–JUNE 2023 179
10.8.2 KEY DEALS 180
TABLE 145 KEY DEALS, JANUARY 2019–JUNE 2023 180
10.8.3 OTHER KEY DEVELOPMENTS 181
TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2019–JUNE 2023 181
11 COMPANY PROFILES 182
11.1 KEY PLAYERS 182
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 THERMO FISHER SCIENTIFIC INC. 182
TABLE 147 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 182
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 183
11.1.2 MERCK KGAA 187
TABLE 148 MERCK KGAA: COMPANY OVERVIEW 187
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022) 188
11.1.3 PROMEGA CORPORATION 191
TABLE 149 PROMEGA CORPORATION: COMPANY OVERVIEW 191
11.1.4 NEOGEN CORPORATION 194
TABLE 150 NEOGEN CORPORATION: COMPANY OVERVIEW 194
FIGURE 43 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022) 195
11.1.5 PERKINELMER INC. 198
TABLE 151 PERKINELMER INC.: COMPANY OVERVIEW 198
FIGURE 44 PERKINELMER INC.: COMPANY SNAPSHOT (2022) 199
11.1.6 AGILENT TECHNOLOGIES, INC. 202
TABLE 152 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 202
FIGURE 45 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 203
11.1.7 PROMOCELL GMBH 206
TABLE 153 PROMOCELL GMBH: COMPANY OVERVIEW 206
11.1.8 DANAHER CORPORATION 207
TABLE 154 DANAHER CORPORATION: COMPANY OVERVIEW 207
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 208
11.1.9 LONZA 210
TABLE 155 LONZA: COMPANY OVERVIEW 210
FIGURE 47 LONZA: COMPANY SNAPSHOT (2022) 211
11.1.10 ABCAM PLC 213
TABLE 156 ABCAM PLC: COMPANY OVERVIEW 213
FIGURE 48 ABCAM PLC: COMPANY SNAPSHOT (2022) 214
11.1.11 3M 216
TABLE 157 3M: COMPANY OVERVIEW 216
FIGURE 49 3M: COMPANY SNAPSHOT (2022) 217
11.1.12 ABNOVA CORPORATION 218
TABLE 158 ABNOVA CORPORATION: COMPANY OVERVIEW 218
11.1.13 GENO TECHNOLOGY INC. 219
TABLE 159 GENO TECHNOLOGY INC.: COMPANY OVERVIEW 219
11.1.14 AAT BIOQUEST, INC. 221
TABLE 160 AAT BIOQUEST, INC.: COMPANY OVERVIEW 221
11.1.15 BIOTHEMA AB 223
TABLE 161 BIOTHEMA AB: COMPANY OVERVIEW 223
11.1.16 BIOTIUM 225
TABLE 162 BIOTIUM: COMPANY OVERVIEW 225
11.1.17 CREATIVE BIOARRAY 226
TABLE 163 CREATIVE BIOARRAY: COMPANY OVERVIEW 226
11.1.18 CANVAX 227
TABLE 164 CANVAX: COMPANY OVERVIEW 227
11.1.19 ELABSCIENCE BIOTECHNOLOGY INC. 228
TABLE 165 ELABSCIENCE BIOTECHNOLOGY INC.: COMPANY OVERVIEW 228
11.1.20 MBL INTERNATIONAL CORPORATION 229
TABLE 166 MBL INTERNATIONAL CORPORATION: COMPANY OVERVIEW 229
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 230
11.2.1 RUHOF CORPORATION 230
11.2.2 CHARM SCIENCES 231
11.2.3 BIO SHIELD TECH, LLC 232
11.2.4 CAYMAN CHEMICAL 233
11.2.5 CELL SIGNALING TECHNOLOGY, INC. 233
12 APPENDIX 234
12.1 INSIGHTS FROM INDUSTRY EXPERTS 234
12.2 DISCUSSION GUIDE 235
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 239
12.4 CUSTOMIZATION OPTIONS 241
12.5 RELATED REPORTS 241
12.6 AUTHOR DETAILS 242
世界のATPアッセイ市場（～2028年）：製品別（消耗品（試薬、マイクロプレート）、機器（ルミノメーター、分光光度計））、用途別（汚染、疾患検査、創薬）、エンドユーザー別（病院、製薬、食品・飲料、学術） |
| 【英語タイトル】ATP Assays Market by Product (Consumables (Reagents, Microplate), Instruments (Luminometer, Spectrophotometer)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, F&B, Academics) - Global Forecast to 2028 | |
 | ・商品コード：AST7417-23 ・発行会社（調査会社）：MarketsandMarkets ・発行日：2023年6月28日 ・ページ数：236 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後24時間以内） ・調査対象地域：グローバル ・産業分野：バイオ |
| Single User（1名様閲覧） | USD4,950 ⇒換算￥742,500 | 見積依頼/購入/質問フォーム |
| Multi User (Five User) | USD6,650 ⇒換算￥997,500 | 見積依頼/購入/質問フォーム |
| Corporate License (全社内共有可) | USD8,150 ⇒換算￥1,222,500 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| マーケッツアンドマーケッツ社の市場調査によると、世界のATPアッセイの市場規模は2023年の3億ドルから、CAGR 7.8%成長し、2028年には5億ドルまで拡大すると見込まれています。こちらの資料では、ATPアッセイの世界市場を対象にし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、用途別（汚染検査、疾患検査、創薬・開発）分析、製品別（消耗品・付属品、機器）分析、エンドユーザー別（製薬・バイオテクノロジー企業、食品・飲料、病院・診断研究所、学術・研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などについて調査・分析を行いました。なお、当資料に記載されている企業情報には、 Thermo Fisher Scientific,Inc. (US)、Promega Corporation (US)、Merck KGaA (Germany)、PerkinElmer,Inc. (US)、Agilent Technologies,Inc. (US)、Abcam plc (UK)、Lonza Group (Switzerland)、Neogen Corporation (US)などが含まれます。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・世界のATPアッセイ市場規模：用途別 - 汚染検査における市場規模 - 疾患検査における市場規模 - 創薬・開発における市場規模 ・世界のATPアッセイ市場規模：製品別 - 消耗品・付属品の市場規模 - 機器の市場規模 ・世界のATPアッセイ市場規模：エンドユーザー別 - 製薬・バイオテクノロジー企業における市場規模 - 食品・飲料における市場規模 - 病院・診断研究所における市場規模 - 学術・研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界のATPアッセイ市場規模：地域別 - 北米のATPアッセイ市場規模 - ヨーロッパのATPアッセイ市場規模 - アジア太平洋のATPアッセイ市場規模 - 中南米のATPアッセイ市場規模 - 中東・アフリカのATPアッセイ市場規模 ・競争状況 ・企業情報 |
“The global ATP Assays market is projected to reach USD 0.5 illion by 2028 from USD 0.3 billion in 2023, at a CAGR of 7.8% during the forecast period.”
Growth in the ATP assays market can primarily be attributed to factors such as the growing investments in pharmaceutical & biotechnology Research & Development, the change from culture-based tests to rapid tests, and rising prevalence of cancer and other infectious diseases. However, the survival of small players and new entrants, are expected to challenge market growth to a certain extent.
“The consumables & accessories segment is projected to account for the largest share of the ATP assays market”
By product, ATP assays market is segmented into consumables & accessories and instruments. The consumables & accessories segment accounted for the largest share of the ATP assays market in 2022.This prevalence can be attributed to the extensive usage of ATP assays in research institutes to evaluate cell viability, the increasing need for tumor testing and cell proliferation (particularly in cancer) due to the rise in chronic diseases, and the frequent acquisition of consumables by pharmaceutical and biotechnology companies.
“Contamination Testing segment is projected to account for the largest share of the ATP assays market in 2023”
By application, the ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. In 2023, the contamination testing segment is projected to account for the largest share of the ATP assays market due to the growing regulatory severity of pharmaceutical and food & beverage companies for non-contaminated production, and the necessity for cleaning and disinfection of environmental surfaces in hospitals.
“By end user, Pharmaceutical & Biotechnology companies accounted for the largest share of the market in 2022”
By end users, The ATP assays market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The dominance of Pharmaceutical & Biotechnology companies segment can be attributed to several significant factors. These include the presence of a substantial number of pharmaceutical players who are making significant investments in this market, the increasing regulatory approvals for cell culture-based vaccines that require the use of ATP assays in contamination testing, the expansion of commercial activities by various pharmaceutical companies, the growing demand for cell and gene therapies to combat chronic diseases.
“By region, North America is projected to account for the largest share of the ATP assays market”
By region,North America accounted for the largest share of the ATP assays market in 2023. Factors such as the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Asia Pacific–20%, Europe–30%, Latin America- 3%, Middle East and Africa–2%
Key players in the ATP Assays Market
The key players operating in the ATP Assays Market include Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), Neogen Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest,Inc. (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology,Inc. (US).
Research Coverage:
The report analyzes the ATP Assays Market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application and end user. The report also includes a product portfolio matrix of various ATP Assays products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Analysis of key drivers (increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests), restraints (the high cost of instruments and inability to differentiate between extracellular and intracellular ATP),opportunities (technological enhancements in ATP Assay probes and growth prospects in emerging markets) and challenges (survival of small players and new entrants) influencing the growth of ATP Assays market.
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global ATP Assays Market. The report analyzes this market by, applications and end user.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the global ATP Assays Market
• Market Development: Comprehensive information on the lucrative emerging markets by applications, products and end user.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global ATP Assays Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, company evaluation quadrant, and capabilities of leading players in the global ATP Assays Market.
❖ レポートの目次 ❖
| ★調査レポート[世界のATPアッセイ市場（～2028年）：製品別（消耗品（試薬、マイクロプレート）、機器（ルミノメーター、分光光度計））、用途別（汚染、疾患検査、創薬）、エンドユーザー別（病院、製薬、食品・飲料、学術）] (コード：AST7417-23)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のATPアッセイ市場（～2028年）：製品別（消耗品（試薬、マイクロプレート）、機器（ルミノメーター、分光光度計））、用途別（汚染、疾患検査、創薬）、エンドユーザー別（病院、製薬、食品・飲料、学術）]についてメールでお問い合わせ |
